Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and nine have given a buy recommendation […]

Shares of JELD-WEN Holding, Inc. (NYSE:JELD – Get Free Report) have been assigned an average rating of “Reduce” from the six analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average twelve-month price […]